Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8K33

SOD1 and Nanobody1 complex

8K33 の概要
エントリーDOI10.2210/pdb8k33/pdb
分子名称Superoxide dismutase [Cu-Zn], NB1, ZINC ION, ... (4 entities in total)
機能のキーワードantibody complex, oxidoreductase/immune system, oxidoreductase-immune system complex
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数24
化学式量合計341459.22
構造登録者
Cheng, S. (登録日: 2023-07-14, 公開日: 2024-07-17, 最終更新日: 2026-01-28)
主引用文献Cheng, S.,Zhong, C.,Zhu, H.,Mu, K.,Jiang, H.,Zhong, P.,Ma, Z.,Liu, X.,Wang, Z.,Liu, R.,Ding, Y.
Structural mechanisms and insights on multiple nanobodies binding diverse SOD1 epitopes.
Commun Biol, 9:30-30, 2025
Cited by
PubMed Abstract: Copper/zinc superoxide dismutase (SOD1) is a crucial metalloenzyme that mitigates oxidative stress by scavenging superoxide anion radicals. Mutations and aggregation of SOD1 are closely linked to the pathogenesis of amyotrophic lateral sclerosis (ALS). Targeting pathogenic SOD1 with nanobodies presents a promising therapeutic approach. We report the first high-resolution crystal structures of SOD1 in complex with three distinct nanobodies (Nb1, Nb2, and Nb3) and their multimeric assemblies (1:2 and 1:3 stoichiometries), revealing distinct binding epitopes primarily mediated by their complementarity determining regions (CDRs) through hydrogen bonds, salt bridges, and hydrophobic interactions. Structural and biophysical analyses using isothermal titration calorimetry (ITC) and fluorescence-detection size-exclusion chromatography (FSEC) demonstrated that all three nanobodies bind SOD1 simultaneously with nanomolar affinities (K values ranging from 23.2 nM to 529 nM). Notably, engineered multimeric tandem nanobodies (Nb1-Nb2-Nb3) achieved higher affinity (K = 4.39 nM) compared to single nanobodies, as validated by ITC. Characterization via dynamic light scattering (DLS) further revealed colloidal stability of SOD1-nanobody complexes. These results provide the first atomic-resolution insights into multi-nanobody targeting of SOD1 without steric interference, establishing a foundation for developing high-affinity tools to detect and manipulate SOD1 in ALS and related neurodegenerative diseases.
PubMed: 41350409
DOI: 10.1038/s42003-025-09293-0
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.13 Å)
構造検証レポート
Validation report summary of 8k33
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon